Psoriasis as a human model of disease to study inflammatory atherogenesis

Keyphrases

• Psoriasis 100%
• Human Model 100%
• Disease Model 100%
• Atherogenesis 100%
• Inflammation 40%
• Cardiovascular Disease 40%
• Cardiovascular Events 40%
• Prospective Cohort Study 20%
• Pathophysiology 20%
• Coronary Computed Tomography Angiography 20%
• Immune Regulation 20%
• Cyclosporine 20%
• Interleukin-23 (IL-23) 20%
• Immune Signaling 20%
• Vascular Disease 20%
• Multimodal Imaging 20%
• Inflammation Diseases 20%
• Anti-tumor Necrosis Factor (anti-TNF) 20%
• Positron Emission Tomography 20%
• Chronic Inflammatory Diseases 20%
• Disease-associated 20%
• Positron Emission Tomography-computed Tomography (PET-CT) 20%
• Anti-IL-17 20%
• Interleukin-17 (IL-17) 20%
• Methotrexate 20%
• Psoriasis Pathogenesis 20%
• Chronic Inflammatory Skin Disease 20%
• Chronic Inflammation 20%
• Vascular Bed 20%
• Cardiovascular Biomarkers 20%
• Shared Links 20%
• Cytokine Inhibitors 20%

Immunology and Microbiology

• Cytokine 100%
• Tumor Necrosis Factor 100%
• Atherosclerosis 50%
• Inflammatory Disorder 50%
• Computed Tomographic Angiography 50%
• Immunomodulation 50%
• Magnetic Resonance Imaging 50%
• Positron Emission Tomography 50%
• Methotrexate 50%
• Ciclosporin 50%
• Dermatitis 50%
• Positron Emission Tomography-Computed Tomography 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Psoriasis 100%
• Atherogenesis 100%
• Diseases 100%
• Inflammation 40%
• Cytokine 40%
• Tumor Necrosis Factor 40%
• Cardiovascular Disease 40%
• Pathophysiology 20%
• Biological Marker 20%
• Vascular Disease 20%
• Prospective Cohort Study 20%
• Atherosclerosis 20%
• Inflammatory Disease 20%
• Methotrexate 20%
• Dermatitis 20%
• Chronic Inflammation 20%
• Ciclosporin 20%